04-Jul-2019

Cancer Registry Software Market Showcase Noteworthy CAGR 10.7% In Global Market Forecast Till 2024

Global Cancer Registry Software Market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.

The Global Cancer Registry Software Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12958

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Cancer Registry Software Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Cancer Registry Software Market?

What is the market drivers, restrains, opportunities governing the Global Cancer Registry Software Market?

Which are the largest and the fastest growing segments in the Global Cancer Registry Software Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/cancer-registry-software-market-mrf-12958

Global Cancer Registry Software Market Research Report By Type (Integrated Software, Standalone Software), Deployment Model (Cloud-Based, On-Premise), Database Type (Commercial, Public), Functionality (Patient Care Management, Product Outcome Evaluation, Cancer Reporting to Meet State, Federal Regulations, Medical Research and Clinical Studies), End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) - Forecast till 2024

Market Scenario

The global cancer registry software market is expected to grow significantly over the forecast period. The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period. Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth.

On the other hand, privacy and data security-related concerns and reluctance to adopt advanced solutions are likely to hamper the growth of the market.

Segmentation

The global cancer registry software market has been segmented into type, deployment model, database type, functionality, and end user.

By type, the market has been segmented into integrated software and standalone software.

Based on the deployment model, the market has been segmented into cloud-based models and on-premise models.

On the basis of the database type, the market has been segmented into commercial databases and public databases.

By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research amp; clinical studies.

The market, by end user, has been segmented into hospitals amp; medical practices, government organizations amp; research centers, pharmaceutical, biotechnology, and medical device companies, and others.

The global cancer registry software market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East amp; Africa. The cancer registry software market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European cancer registry software market has been segmented into Western Europe and Eastern Europe. Western Europe cancer registry software market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The cancer registry software market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cancer registry software market in the Middle East amp; Africa has been segmented into the Middle East and Africa.

Global Cancer Registry Software Market, by Key Players

Onco, Inc.
Rocky Mountain Cancer Data Systems
McKesson Corporation
Elekta AB (PUB)
C/Net Solutions
Electronic Registry Systems, Inc.
ROCKY MOUNTAIN CANCER DATA SYSTEMS
MCKESSON CORPORATION
ORDINAL DATA, INC
CONDUENT, INC
IBM
HIMAGINE SOLUTIONS INC

Regional Market

On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the rising prevalence of cancer, innovative product development and increasing investment in research and development for innovation in the region. According to the National Cancer Institute, there were 1,735,350 new cases of cancer in the US in 2018.
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic amp; research base and availability of funding for research in the European countries.

Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.

The Middle East amp; Africa has the least share of the global cancer registry software market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

Global Cancer Registry Software Market, by Type

Integrated Software
Standalone Software

Global Cancer Registry Software Market, by Deployment Model

Cloud-Based Models
On-Premise Models

Global Cancer Registry Software Market, by Database Type

Commercial Databases
Public Databases

Global Cancer Registry Software Market, by Functionality

Patient Care Management
Product Outcome Evaluation
Cancer Reporting to Meet State and Federal Regulations
Medical Research amp; Clinical Studies

Global Cancer Registry Software Market, by End User

Hospitals amp; Medical Practices
Government Organizations amp; Research Centers
Pharmaceutical, Biotechnology, and Medical Device Companies
Others

Global Cancer Registry Software Market, by Region

Americas
North America
US
Canada
Latin America
Europe
Western Europe
Germany
France
Italy
Spain
UK
Rest of Western Europe
Eastern Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
The Middle East amp; Africa
Middle East
Africa

Intended Audience

Software companies
Contract research organizations
Academic and research institutes
Government associations

Table Of Contents

Cancer Registry Software Market Research Report - Global Forecast till 2024

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porterrsquo;s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Cancer Registry Software Market, By Type

6.1 Introduction

6.2 Integrated Software